Breaking News Instant updates and real-time market news.

PEP

PepsiCo

$118.00

1.7 (1.46%)

, FB

Facebook

$184.31

6.55 (3.68%)

12:08
08/06/18
08/06
12:08
08/06/18
12:08

Fly Intel: Wall Street's top stories at midday

Stocks began the session in negative territory and almost immediately moved into drift mode. Before falling too far, the Dow reversed and began to pare its losses until eventually joining the other averages in positive territory. The domestic economic calendar has been quiet, but there were several earnings reports released as the earnings season begins to wind down. Oil prices have been climbing for most of the morning and are now approaching $70 a barrel. ECONOMIC EVENTS: In the U.S., no economic data of note was reported. COMPANY NEWS: PepsiCo (PEP) announced that Ramon Laguarta will succeed Indra Nooyi as CEO when she steps down in October after 24 years with the company, the last 12 as CEO. Laguarta, who has spent 22 years at PepsiCo, has served as President since September 2017... Shares of Facebook (FB) rose 4% in morning trading after The Wall Street Journal reported that over the past year the company has asked JPMorgan (JPM), Wells Fargo (WFC), Citi (C) and U.S. Bancorp (USB) to share detailed financial information about their customers so that the social media giant could offer products to bank customers on Messenger. Facebook has talked about a feature to show its users their checking-account balances and also pitched fraud alerts, the Journal added... Praxair (PX) has fallen 4% after Linde (LNEGY) announced late Friday that discussions with various antitrust authorities have resulted in further indications that merger clearances for the companies' proposed combination could be subject to requirements "more onerous than previously expected." MAJOR MOVERS: Among the noteworthy gainers was Web.com (WEB), which rose 11% to $28.28 after it announced an ammended agreement to be acquired by Siris Capital affiliates for $28 per share, up from the prior price of $25 per share. Also higher were SeaWorld (SEAS) and Tyson Foods (TSN), which gained a respective 16% and 4% after reporting quarterly results. Among the notable losers was Acadia (ACAD), which slid 7% after Piper Jaffray analyst Danielle Brill downgraded the stock to Neutral from Overweight and cut the firm's price target for the shares to $19 from $61 after taking over coverage. Also lower were Newell (NWL) and Sotheby's (BID), which fell 14% and 6%, respectively, after reporting quarterly results. INDEXES: Near midday, the Dow was up 31.52, or 0.12%, to 25,494.10, the Nasdaq was up 24.09, or 0.31%, to 7,836.10, and the S&P 500 was up 7.65, or 0.27%, to 2,848.00.

PEP

PepsiCo

$118.00

1.7 (1.46%)

FB

Facebook

$184.31

6.55 (3.68%)

PX

Bought by LIN

$158.58

-5.64 (-3.43%)

WEB

Web.com

$28.25

2.85 (11.22%)

SEAS

SeaWorld

$24.45

3.33 (15.77%)

TSN

Tyson Foods

$60.05

2.27 (3.93%)

ACAD

Acadia

$14.19

-1.04 (-6.83%)

NWL

Newell Brands

$22.87

-3.7 (-13.93%)

BID

Sotheby's

$49.77

-3.13 (-5.92%)

LNEGY

Ticker now LIN

$0.00

(0.00%)

  • 06

    Aug

  • 06

    Aug

  • 06

    Aug

  • 06

    Aug

  • 08

    Aug

  • 30

    Aug

  • 31

    Aug

  • 28

    Oct

PEP PepsiCo
$118.00

1.7 (1.46%)

07/24/18
RHCO
07/24/18
NO CHANGE
Target $110
RHCO
Hold
PepsiCo price target raised to $110 from $105 at SunTrust
SunTrust analyst William Chappell raised his price target on PepsiCo to $110 to account for gains related to the impact of refranchising transactions, which he expects to support the company's high-single-digit EPS growth trend going forward. The analyst also keeps his Hold rating on PepsiCo as the stock is "fairly valued", with the company's Beverage business trading in line with peers and the Food business trading at the high end of its large-cap snack food peer range.
07/11/18
BMOC
07/11/18
NO CHANGE
Target $110
BMOC
Market Perform
PepsiCo stock price advance looks 'overdone', says BMO Capital
BMO Capital analyst Amit Sharma kept his Market Perform rating and $110 price target on PepsiCo after its Q2 earnings beat, saying the 18% increase in the company's share price over the past two months now looks "overdone". Sharma notes that it is harder to determine whether PepsiCo's earnings growth model is sustainable or stretched "given flexibility around marketing/brands investments", adding that he is also less confident on management's ability/willingness to consistently top consensus. Moreover, despite the company's maintained outlook for FY18, the analyst sees non-recurring items such as the bottling asset sale, tax cuts, and pension income to contribute over 600bps to the expected FY18 EPS growth - a much higher contribution than the 250bps seen in FY17.
07/16/18
RBCM
07/16/18
NO CHANGE
Target $75
RBCM
Outperform
Monster Beverage price hike to come November 1st, says RBC Capital
RBC Capital analyst Nik Modi says his industry sources have confirmed that Monster Beverage (MNST) intends to raise its prices by 4.0-5.5% on November 1st depending on the pack size, which would be in line with the management's indication of pricing review made at the June shareholder meeting. The analyst keeps his Outperform rating and $75 price target on Monster, adding that Coca Cola (KO), PepsiCo (PEP) and Keurig Dr Pepper (KDP) will also likely make pricing changes in response over the coming months.
07/23/18
JEFF
07/23/18
NO CHANGE
Target $107
JEFF
Hold
Jefferies sees risk of near-term downside in PepsiCo shares
Jefferies analyst Kevin Grundy sees potential near-term downside in shares of PepsiCo. Despite fundamental challenges and weak earnings quality, PepsiCo's "relative multiple remains elevated," Grundy tells investors in a research note. The analyst is "negatively biased" toward PepsiCo and reiterates a Hold rating on the shares with a $107 price target.
FB Facebook
$184.31

6.55 (3.68%)

07/30/18
MZHO
07/30/18
NO CHANGE
Target $25
MZHO
Underperform
Twitter should trade at discount to Facebook, says Mizuho
Mizuho analyst James Lee says that while Twitter (TWTR) reported "strong" Q2 results, EBITDA and implied revenue guidance for Q3 was below consensus by 16% and 6%, respectively. Management cited the health initiative that will slow down active user growth and increase operating expenditures due to headcount additions, Lee tells investors in a post-earnings research note. He keeps an Underperform rating on Twitter shares with a $25 price target, which represents 12.5 times his 2020 EBITDA estimate. The analyst believes the stock should trade at a discount to his Facebook (FB) target of 13.5 times EBITDA.
08/06/18
STFL
08/06/18
NO CHANGE
Target $202
STFL
Buy
Facebook added to Stifel Select List, Amazon removed
Stifel analyst Scott Devitt replaced Amazon (AMZN) with Facebook (FB) on the Stifel Select List, citing the strong year-to-date performance of Amazon shares, which he still likes and keeps a Buy rating upon. He believes Facebook expectations, and the shares, are appropriately set to allow for longer-term outperformance given the material reset that followed the company's "painful" Q2 update, Devitt tells investors. He maintains a Buy rating and $202 price target on Facebook.
08/06/18
MSCO
08/06/18
NO CHANGE
MSCO
Boeing, Tesla, Nvidia make Morgan Stanley 'key man risk' list
Morgan Stanley equity strategist Mark Savino noted that about 12% of CEO jobs among S&P 500 companies turned over in 2017, noting that this was the highest level of CEO departures since before the financial crisis. The 59 stocks of S&P 500 companies that had CEOs depart in 2017 underperformed the market by 11% over the next 12 months, or since the departure for instances that were less than 12 months ago, noted Savino. In cooperation with the firm's U.S. analysts, Savino and his team identified the companies in each sector they believe face the greatest level of "key man risk," which includes: Boeing (BA), Tesla (TSLA), ADT Inc. (ADT), Moody's (MCO), TransUnion (TRU), Arista Networks (ANET), Church & Dwight (CHD), Coca-Cola (KO), Monster Beverage (MNST), Coupa Software (COUP), Salesforce (CRM), FireEye (FEYE), MongoDB (MDB), Microsoft (MSFT), New Relic (NEWR), XPO Logistics (XPO), Hilton (HLT), Las Vegas Sands (LVS), Best Buy (BBY), Ulta (ULTA), Aflac (AFL), Athene Holding (ATH), Lincoln National (LNC), Arthur J. Gallagher (AJG), Chubb (CB), Amazon.com (AMZN), Activision Blizzard (ATVI), Facebook (FB), Alphabet (GOOGL), Apple (AAPL), Terex (TEX), Cleveland-Cliffs (CLF), Freeport McMoRan (FCX), FleetCor (FLT), Global Payments (GPN), Square (SQ), Jazz Pharmaceuticals (JAZZ), Cheesecake Factory (CAKE), Broadcom (AVGO), Nvidia (NVDA), Chegg (CHGG), DXC Technology (DXC), Medidata (MDSO), Pluralsight (PS), RealPage (RP), Shopify (SHOP) and T-Mobile (TMUS).
08/02/18
MKMP
08/02/18
NO CHANGE
Target $230
MKMP
Buy
Facebook price target lowered to $230 from $255 at MKM Partners
MKM Partners analyst Rob Sanderson lowered his price target on Facebook to $230 but kept his Buy rating, saying investors should "take advantage" of the "second capitulation" in the stock. The analyst says the current valuation multiple is too low after the management's "aggressively conservative" outlook relative to consensus even though growth deceleration is nearing, with consensus pricing in about 15% of revenue slowdown in the next two quarters.
PX Bought by LIN
$158.58

-5.64 (-3.43%)

05/30/18
JPMS
05/30/18
UPGRADE
JPMS
Overweight
Linde upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Alberto Rueda upgraded Linde (LNEGY) to Overweight and raised his price target for the shares to EUR 217 from EUR 212. The analyst has increased confidence in "substantial" upside from the proposed merger with Praxair (PX).
03/27/18
BMOC
03/27/18
INITIATION
Target $159
BMOC
Market Perform
Praxair initiated with a Market Perform at BMO Capital
BMO Capital analyst John McNulty started Praxair with a Market Perform rating and $159 price target.
03/19/18
SBSH
03/19/18
NO CHANGE
SBSH
Buy
Praxair shares could fall 10%-15% initially if deal fails, says Citi
Citi analyst P.J. Juvekar believes Praxair (PX) shares could initially fall 10%-15% if the merger with Linde were to fail due to regulatory restrictions. The analyst, however, thinks shares should eventually trade based on its standalone merits, which he remains positive on. He recommends playing the deal through Praxair over Linde. Juvekar keeps a Buy rating on the shares.
08/06/18
JEFF
08/06/18
NO CHANGE
Target $194
JEFF
Buy
Jefferies still sees over 85% chance of Linde, Praxair merger
Jefferies analyst Laurence Alexander believes additional concerns from the Federal Trade Commission will precipitate additional asset sales at "relatively low multiples" in order to close merger between Linde (LNEGY) and Praxair (PX). The analyst estimates a 35c earnings per share buffer for Praxair on 2020 estimates before "defending a near-term value dilutive deal becomes an issue." Pending more detail, Alexander pegs the deal probability at greater than 85%. In the event of the deal failing, the analyst would expect Praxair management to "immediately announce a plan to ratchet up buybacks." He keeps a Buy rating on Praxair with a $194 price target.
WEB Web.com
$28.25

2.85 (11.22%)

06/21/18
RHCO
06/21/18
NO CHANGE
Target $24
RHCO
Buy
Web.com could attract competing takeover suitors, says SunTrust
SunTrust analyst Naved Khan believes Web.com's acquisition by Siris Capital Group for $25 per share could generate interest from other potential suitors. Given the 45 day go-shop period and break-up fee terms, along with Web.com's portfolio of assets and free cash flow characteristics, we could potentially see interest from other parties interested in the entire business or individual pieces, Khan tells investors in a research note. The analyst keeps a Buy rating on the shares with a $24 price target. The stock in afternoon is trading above the offer price at $25.40, up 9.5% or $2.20.
06/27/18
RHCO
06/27/18
NO CHANGE
Target $30
RHCO
Buy
Web.com price target raised to $30 from $24 at SunTrust
SunTrust analyst Naved Khan raised his price target on Web.com to $30, maintaining his view that the company's agreed acquisition by Siris Capital at $25 per share could generate interest from other potential buyers. Among the potential acquirers, the analyst lists Silver Lake, KKR (KKR), Vector Capital, and GoDaddy (GDDY).
08/01/18
RILY
08/01/18
NO CHANGE
Target $25
RILY
Neutral
Web.com price target raised to $25 from $19 at B. Riley FBR
B. Riley FBR analyst Sameet Sinha raised his price target for Web.com to $25 after citing the company's Q2 beat on average revenue per user gains. The analyst notes that guidance was not updated and he keeps a Neutral rating on the shares.
08/06/18
NORL
08/06/18
DOWNGRADE
Target $28
NORL
Market Perform
Web.com downgraded to Market Perform from Outperform at Northland
Northland analyst Tim Klasell downgraded Web.com to Market Perform with an unchanged price target of $28, citing the company's announcement that it is being acquired by Siris Capital at an amended price of $28 per share.
SEAS SeaWorld
$24.45

3.33 (15.77%)

07/09/18
07/09/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Procter & Gamble (PG) downgraded to Hold from Buy at Jefferies with analyst Kevin Grundy saying slowing market growth, volatility in emerging markets, U.S. retail difficulties, the stronger U.S. dollar and "pricing challenges" should drive estimates lower. 2. SeaWorld (SEAS) and Six Flags (SIX) were downgraded to Market Perform from Outperform at Wells Fargo. 3. Walgreens Boots Alliance (WBA) downgraded to Neutral from Buy at Citi with analyst Ralph Giacobbe saying he finds it difficult to argue for "meaningful multiple expansion" given headwinds from industry pressures and a dynamic and changing backdrop. 4. Flowers Foods (FLO) downgraded to Hold from Buy at Vertical Group. 5. Wayfair (W) downgraded to Market Perform from Outperform with the firm citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/18/18
STFL
07/18/18
NO CHANGE
Target $27
STFL
Buy
SeaWorld shorts may be 'chased' by earnings report catalysts, says Stifel
Stifel analyst Steven Wieczynski said he expects SeaWorld's Q2 earnings announcement to include four potential catalysts, which he ranks from most likely to least likely as an EBITDA beat, John Reilly being named permanent CEO, a long-range EBITDA target being established, and refinancing of loans due May 2020 being announced. While seeing all four is "somewhat of a longshot," he has a high degree of confidence in the first three and would expect to see "additional shorts chased from the name" if the catalysts he is calling for are in the report. Wieczynski raised his price target on SeaWorld shares ahead of the report to $27 from $25 and keeps a Buy rating on the name.
07/09/18
07/09/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. GAMESTOP STARTED WITH A BUY: Jefferies analyst Stephanie Wissink started GameStop (GME) with a Buy rating and $18 price target. Her contrarian view on the stock is that under potential new leadership with a well defined vision and execution plan, the stock's valuation, which she feels is "overlooked and overly discounted," could improve. GameStop is higher by 2.5% in midday trading. PIPER SEES CISCO LOSING SECURITY SHARE TO PALO ALTO: Piper Jaffray analyst James Fish says his firm's recent channel survey work across networking and security were weaker than he's seen in past calendar quarters for Cisco Systems (CSCO). Cisco's Security survey results were "especially weak," implying Palo Alto Networks (PANW) is taking market share, the analyst said, although the former remains his top networking pick. He kept an Overweight rating on Cisco shares, which were down almost 1% in midday trading. JEFFERIES DOWNGRADES P&G: Jefferies analyst Kevin Grundy downgraded Procter & Gamble (PG) to Hold from Buy and lowered his price target for the shares to $79 from $83. Slowing market growth, volatility in emerging markets, U.S. retail difficulties, the stronger U.S. dollar and "pricing challenges" should drive estimates lower, Grundy told investors in a research note titled "Tide Unlikely to Turn: Downgrade to Hold as Bull Thesis Wanes." Grundy said he preferred shares of Church & Dwight (CHD) and Energizer (ENR) for exposure to the Home and Personal Care space. TRADE DESK STARTED WITH A SELL: Pivotal Research analyst Brian Wieser initiated Trade Desk (TTD) with a Sell rating and $58 price target, stating that he believes the company can grow rapidly this year but should then see its growth decelerate. He believes its growth will plateau at a size smaller than Criteo's (CRTO), on which Wieser also initiated coverage this morning with a Buy rating. WELLS FARGO DOWNGRADES TWO THEME PARKS: Wells Fargo analyst Timothy Conder downgraded both SeaWorld (SEAS) and Six Flags (SIX) to Market Perform from Outperform, citing valuation, negative seasonal trading patterns, and weather impact, despite ongoing favorable consumer fundamentals and the key Q3 just starting. SeaWorld is trading down 1.3%, while Six Flags is down 1.7% at midday.
07/09/18
WELS
07/09/18
DOWNGRADE
WELS
Market Perform
Six Flags downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo downgraded Six Flags (SIX) to Market Perform from Outperform, citing valuation, negative seasonal trading patterns and incremental FX related UK/Brazilian headwinds, despite ongoing favorable consumer fundamentals and the key Q3 just starting. Wells Fargo also downgraded SeaWorld (SEAS) to Market Perform this morning.
TSN Tyson Foods
$60.05

2.27 (3.93%)

07/30/18
JEFF
07/30/18
NO CHANGE
Target $77
JEFF
Underperform
Chicken prices have trended below expectations, says Jefferies
Jefferies analyst Akshay Jagdale says that chicken prices have trended below expectations owing to a further weakening of demand since his last chicken industry update. The analyst attributes the demand weakness to an increase in availability of competing proteins and to a lesser extent lower exports amid trade war concerns. He expects "demand to remain weak and supply growth to pick up." As such, Jagdale lowered his estimates for Sanderson Farms (SAFM), Pilgrim's Pride (PPC) and Tyson Foods (TSN). The analyst keeps an Underperform rating on Sanderson with a $77 price target, Buy rating on Tyson with an $85 price target, and Holding rating on Pilgrim's with a reduced price target of $19.
07/30/18
PIVT
07/30/18
NO CHANGE
Target $40
PIVT
Sell
Tyson Foods price target lowered to $40 from $55 at Pivotal Research
Pivotal Research analyst Timothy Ramey said Tyson Foods did not give a lot of detail to its lowering of its FY18 guidance, but he notes that the company's view was cut to below his "Street-low" estimate of $6.10. Ramey, who thinks the company is "well past the top" on margins for all three of its major segments, lowered his price target on Tyson shares to $40 from $55 and keeps a Sell rating on the stock.
07/30/18
SPHN
07/30/18
NO CHANGE
Target $73
SPHN
Overweight
Tyson Foods price target lowered to $73 from $82 at Stephens
Stephens analyst Farha Aslam lowered her price target on Tyson Foods shares to $73 after the company cut its FY18 adjusted EPS view to $5.70-$6.00 from $6.55-$6.70, stating that commodity fundamentals are weak but she believes the valuation is attractive with the shares trading at a 5-year low in terms of valuation compared to forward earnings. Tyson is making operational improvements that should support the company's long-term earnings growth, said Aslam, who keeps an Overweight rating on Tyson shares.
07/31/18
PIPR
07/31/18
NO CHANGE
Target $70
PIPR
Overweight
Tyson Foods price target lowered to $70 from $92 at Piper Jaffray
Piper Jaffray analyst Michael Lavery lowered his price target for Tyson Foods to $70 after the company reduced its outlook for fiscal 2018. Oversupply in protein are driving down selling prices faster than costs are falling and tariffs are driving down export demand, Lavery tells investors in a research note. Tyson has some partially offsetting cost favorability from lower hog and feed costs, however, the analyst adds. He keeps an Overweight rating on Tyson Foods.
ACAD Acadia
$14.19

-1.04 (-6.83%)

04/26/18
JPMS
04/26/18
NO CHANGE
JPMS
Overweight
JPMorgan still sees low risk of Acadia drug being pulled from market
JPMorgan analyst Cory Kasimov continues to see a low, "but not zero," risk of Acadia Pharmaceuticals' Nuplazid being pulled from the market. Yesterday's CNN report is "mostly noise" and "nothing new," Kasimov told investors last night in a research note. The analyst, however, says he can appreciate the impact of the FDA Commissioner indicating he would "take another look" at the drug's safety profile. Kasimov predicates his views on the formal FDA review and the agency's initial statement that Nuplazid's safety profile is consistent with the label, as well as additional commentary he received yesterday from management. The analyst views yesterday's pullback in shares of Acadia as "fundamentally unjustified based on current information." He kept an Overweight rating on the stock. Shares of Acadia are up 5% to $15.95 in early trading.
08/06/18
08/06/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Equal Weight from Overweight at Barclays with analyst Blayne Curtis saying he believes upside in the shares will be challenging until the company's margins bottom. 2. Immune Pharmaceuticals (IMNP) downgraded to Hold from Buy at Maxim with analyst Jason McCarthy citing the company's delisting from Nasdaq and evaluation of strategic options as it seeks to resolve its financing overhang. 3. Flowers Foods (FLO) downgraded to Equal Weight from Overweight at Consumer Edge. 4. CommScope (COMM) downgraded to Hold from Buy at Jefferies with analyst George Notter saying after "further reflection" from the earnings call and conversations with industry contacts, he believes CommScope's Mobility division performance will not improve this year or next. 5. Acadia (ACAD) downgraded to Neutral from Overweight at Piper Jaffray with analyst Danielle Brill saying the recent negative headlines related to potential Nuplazid safety issues will continue to weigh on sales and the shares for the foreseeable future. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/06/18
08/06/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. INTERCEPT DOUBLE UPGRADED AT GOLDMAN: Goldman Sachs analyst Salveen Richter double upgraded Intercept Pharmaceuticals (ICPT) to Buy from Sell and raised his price target for the shares to $157 from $46. The analyst said Ocaliva in fatty liver disease nonalcoholic steatohepatitis is the crux of Intercept's value proposition and that he's positive into the Phase 3 Regenerate interim readout in the first half of 2019. Intercept should benefit from Ocaliva's global first-mover advantage in NASH, Richter said. In late morning trading, Intercept shares are up 12%. BUCKINGHAM UPGRADES SQUARE TO BUY: Buckingham upgraded Square (SQ) to Buy from Neutral and raised its price target to $85 from $65. Analyst Chris Brendler said the strong Q2 results reduced his concerns about high valuation and competition and said there is no reason why Square will not continue to report better then expected core revenue growth into 2020. Brendler said long-run adjusted EBITDA margins of 40%-50% justify a higher valuation. PIPER CUTS ACADIA TO NEUTRAL: Piper Jaffray analyst Danielle Brill downgraded Acadia Pharmaceuticals (ACAD) to Neutral from Overweight and cut her firm's price target on shares to $19 from $61 after taking over coverage of the name. The recent negative headlines related to potential Nuplazid safety issues will continue to weigh on sales and the shares for the foreseeable future, Brill said. Further, the analyst does not have a high level of conviction for positive data from Acadia's near-term catalysts, namely the Phase 2 major depressive disorder data in September and the Phase 2 negative schizophrenia symptoms readout in the first half of 2019. BARCLAYS CUTS INTEL TO EQUAL WEIGHT: Barclays analyst Blayne Curtis downgraded Intel (INTC) to Equal Weight from Overweight and cut his price target for the shares to $53 from $62. The analyst believes upside in the shares will be challenging until the company's margins bottom. JEFFERIES SAYS OHIO INCIDENT NOT A RISK TO CHIPOTLE TRAFFIC: After analyzing digital engagement with the brand from last week and compared to the Virginia incident last July, Jefferies analyst Andy Barish does not believe the illnesses at the Ohio restaurant put Chipotle Mexican Grill's (CMG) traffic trends at risk. The analyst believes Chipotle's procedures were followed in Ohio, the number of cases was not substantiated, and the company did a better job controlling the narrative and taking action. Barish kept a Buy rating on Chipotle shares with a $550 price target.
08/06/18
PIPR
08/06/18
DOWNGRADE
Target $19
PIPR
Neutral
Acadia downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Danielle Brill downgraded Acadia Pharmaceuticals to Neutral and cut her firm's price target for the shares to $19 from $61 after taking over coverage of the name. The stock closed Friday down 27c to $15.22. The recent negative headlines related to potential Nuplazid safety issues will continue to weigh on sales and the shares for the foreseeable future, Brill tells investors in a research note. Further, the analyst does not have a high level of conviction for positive data from Acadia's near-term catalysts, namely the Phase 2 major depressive disorder data in September and the Phase 2 negative schizophrenia symptoms readout in the first half of 2019.
NWL Newell Brands
$22.87

-3.7 (-13.93%)

04/17/18
WELS
04/17/18
UPGRADE
WELS
Outperform
Newell Brands upgraded to Outperform from Market Perform at Wells Fargo
04/17/18
WELS
04/17/18
UPGRADE
Target $33
WELS
Outperform
Newell Brands upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Bonnie Herzog upgraded Newell Brands to Outperform and raised her price target for the shares to $33 from $25. The stock's setup is good looking forward, with greater potential upside than downside risk over the next 12 months, Herzog tells investors in a research note. She calls her upgrade more of an event-driven break-up call versus a fundamental improvement call. The analyst's break-up analysis suggests the targeted $10B after-tax proceeds from the planned divestitures could prove conservative. Newell's current valuation is not reflective of its underlying value, Herzog contends.
04/17/18
04/17/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Hold from Sell at Pivotal Research with analyst Brian Wieser saying the company "has a lot of positive elements" heading into the back half of the year, including a strong film slate, the launch of new direct to consumer over-the-top services, and efforts in support of the close of the Fox (FOXA) transaction. 2. Coca-Cola (KO) upgraded to Neutral from Sell at Goldman Sachs with analyst Judy Hong saying she sees an improving organic sales growth outlook, "cleaner base" post-refranchising, and better visibility on its margin and earnings targets. 3. Merck (MRK) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst David Risinger saying the Keytruda+chemo combination showed better than expected results in lung cancer, boosting the company's immuno-oncology lead against Bristol-Myers (BMY). 4. Newell Brands (NWL) upgraded to Outperform from Market Perform at Wells Fargo with analyst Bonnie Herzog saying the stock's setup is good looking forward, with greater potential upside than downside risk over the next 12 months. 5. Twitter (TWTR) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Brian Nowak citing recent advertiser conversations that have continued to be incrementally positive about Twitter's ad business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/27/18
03/27/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Newell Brands (NWL) downgraded to Hold from Buy at SunTrust with analyst William Chappell saying the stock is in "no-man's land" for a few quarters after its decision to increase its asset sale to $10B from $6B without disclosing which assets are sold following its recent agreement with activist shareholder Starboard Value. 2. Macerich (MAC) and Simon Property (SPG) were downgraded to Neutral from Overweight at JPMorgan. 3. Kimco Realty (KIM) downgraded to Underweight from Equal Weight at Morgan Stanley with analyst Richard Hill saying he is cautious on REITs in general, but higher quality strips are better positioned to mitigate decelerating growth risks. 4. Range Resources (RRC) downgraded to Market Perform from Outperform at Bernstein with analyst Bob Brackett saying he believes gas levered names, particularly those with significant debt loads, are likely to struggle as gas prices compress cash margins. 5. Dominion Midstream (DM) downgraded to In Line from Outperform at Evercore ISI. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BID Sotheby's
$49.77

-3.13 (-5.92%)

06/12/18
SIDC
06/12/18
DOWNGRADE
SIDC
Neutral
Sotheby's downgraded to Neutral from Buy at Sidoti
06/12/18
06/12/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. SeaWorld (SEAS) downgraded to Sell from Neutral at Citi with analyst Jason Bazinet saying given the high short interest, a short squeeze ensued after SeaWorld beat the Street's Q1 EBITDA expectation by a wide margin. 2. Sotheby's (BID) downgraded to Neutral from Buy at Sidoti. 3. Buckeye Partners (BPL) downgraded to Neutral from Buy at UBS with analyst Shneur Gershuni saying Buckeye will enter a period of "sideways performance" until its growth comes online. 4. Brown-Forman (BF.A, BF.B) downgraded to Sell from Hold at Societe Generale. 5. Barrick Gold (ABX) downgraded to Underweight from Equal Weight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/30/17
10/30/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Sotheby's (BID) initiated with a Buy at Aegis. 2. Alnylam (ALNY) initiated with a Buy at FBR Capital. 3. Adamas Pharmaceuticals (ADMS) initiated with an Outperform at Evercore ISI. 4. Vipshop (VIPS) initiated with a Neutral at UBS. 5. Rhythm Pharmaceuticals (RYTM) initiated with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/30/17
AGIS
10/30/17
INITIATION
Target $60
AGIS
Buy
Sotheby's initiated with a Buy at Aegis
Aegis analyst Rommel Dionisio initiated Sotheby's with a Buy rating and $60 price target, citing its "lucrative" profit margins, the high barriers to additional competition beyond "archrival" Christie's and the company's increased focus on shareholder value.
LNEGY Ticker now LIN
$0.00

(0.00%)

TODAY'S FREE FLY STORIES

VMI

Valmont

$136.23

2.79 (2.09%)

17:33
03/18/19
03/18
17:33
03/18/19
17:33
Hot Stocks
Valmont announces Nebraska site closure »

This past week, many…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

FLDM

Fluidigm

$13.78

0.12 (0.88%)

17:32
03/18/19
03/18
17:32
03/18/19
17:32
Syndicate
Breaking Syndicate news story on Fluidigm »

Fluidigm files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOX

21st Century Fox

$51.06

-0.64 (-1.24%)

, FOXA

21st Century Fox

$51.38

-0.57 (-1.10%)

17:26
03/18/19
03/18
17:26
03/18/19
17:26
Hot Stocks
Fox, Disney announces distribution adjustment multiple for acquisition »

Twenty-First Century Fox…

FOX

21st Century Fox

$51.06

-0.64 (-1.24%)

FOXA

21st Century Fox

$51.38

-0.57 (-1.10%)

DIS

Disney

$113.07

-1.89 (-1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

XYF

X Financial

$6.23

0.715 (12.98%)

17:23
03/18/19
03/18
17:23
03/18/19
17:23
Earnings
X Financial reports Q4 EPS 24c, two estimates 24c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 20

    Mar

CADE

Cadence Bancorp

$20.24

0.51 (2.58%)

17:22
03/18/19
03/18
17:22
03/18/19
17:22
Hot Stocks
Cadence Bancorp President Samuel Tortorici buys almost $1M in company shares »

Cadence Bancorp President…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

CELP

Cypress Energy

$7.41

0.06 (0.82%)

17:22
03/18/19
03/18
17:22
03/18/19
17:22
Syndicate
Breaking Syndicate news story on Cypress Energy »

Cypress Energy files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

JWN

Nordstrom

$44.21

0.465 (1.06%)

17:21
03/18/19
03/18
17:21
03/18/19
17:21
Syndicate
Breaking Syndicate news story on Nordstrom »

Nordstrom files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$171.73

2.13 (1.26%)

17:20
03/18/19
03/18
17:20
03/18/19
17:20
Hot Stocks
General Dynamics awarded $2.04B Navy submarine material contract modification »

General Dynamics has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

FFIN

First Financial

$61.60

0.44 (0.72%)

, MBFI

MB Financial

$47.20

0.63 (1.35%)

17:19
03/18/19
03/18
17:19
03/18/19
17:19
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

First Financial…

FFIN

First Financial

$61.60

0.44 (0.72%)

MBFI

MB Financial

$47.20

0.63 (1.35%)

FOE

Ferro

$18.88

0.125 (0.67%)

FITB

Fifth Third

$28.74

0.42 (1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 16

    Apr

  • 23

    Apr

  • 23

    Apr

FOE

Ferro

$18.88

0.125 (0.67%)

, FFIN

First Financial

$61.60

0.44 (0.72%)

17:17
03/18/19
03/18
17:17
03/18/19
17:17
Hot Stocks
Breaking Hot Stocks news story on Ferro, First Financial »

Ferro to replace First…

FOE

Ferro

$18.88

0.125 (0.67%)

FFIN

First Financial

$61.60

0.44 (0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

FFIN

First Financial

$61.60

0.44 (0.72%)

, MBFI

MB Financial

$47.20

0.63 (1.35%)

17:17
03/18/19
03/18
17:17
03/18/19
17:17
Hot Stocks
First Financial to replace MB Financial in S&P 400 at open on 3/22 »

Fifth Third Bancorp…

FFIN

First Financial

$61.60

0.44 (0.72%)

MBFI

MB Financial

$47.20

0.63 (1.35%)

FITB

Fifth Third

$28.74

0.42 (1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 16

    Apr

  • 23

    Apr

  • 23

    Apr

CUTR

Cutera

$18.00

-0.29 (-1.59%)

17:13
03/18/19
03/18
17:13
03/18/19
17:13
Hot Stocks
Cutera director Daniel Plants buys almost $1.5M in company shares »

Cutera director Daniel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Mar

SMTX

SMTC Corp.

$4.41

-0.1 (-2.22%)

17:13
03/18/19
03/18
17:13
03/18/19
17:13
Syndicate
Breaking Syndicate news story on SMTC Corp. »

SMTC Corp. files $50M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 28

    May

SNE

Sony

$46.10

-0.16 (-0.35%)

, AAPL

Apple

$188.03

1.83 (0.98%)

17:09
03/18/19
03/18
17:09
03/18/19
17:09
Periodicals
PlayStation Vue now lets Apple TV users watch four channels at once, Verge says »

According to the…

SNE

Sony

$46.10

-0.16 (-0.35%)

AAPL

Apple

$188.03

1.83 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRRM

Verra Mobility

$10.89

0.15 (1.40%)

17:08
03/18/19
03/18
17:08
03/18/19
17:08
Earnings
Verra Mobility reports Q4 net ($38.0M) vs. ($29.2M) last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

EQH

AXA Equitable

$20.86

0.09 (0.43%)

17:06
03/18/19
03/18
17:06
03/18/19
17:06
Syndicate
AXA Equitable files to sell 40M shares of common stock for holders »

In connection with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$113.07

-1.89 (-1.64%)

17:04
03/18/19
03/18
17:04
03/18/19
17:04
Hot Stocks
ESPN+ to become exclusive distributor of UFC Pay-Per-View events »

UFC and ESPN+ announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Apr

STML

Stemline

$12.92

-0.71 (-5.21%)

17:02
03/18/19
03/18
17:02
03/18/19
17:02
Recommendations
Stemline analyst commentary at Piper Jaffray »

Stemline sees positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

REV

Revlon

$19.39

0.42 (2.21%)

17:02
03/18/19
03/18
17:02
03/18/19
17:02
Hot Stocks
Revlon down 15% after Q4 results miss estimates »

The company also…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

ATR

AptarGroup

$103.69

0.75 (0.73%)

17:01
03/18/19
03/18
17:01
03/18/19
17:01
Hot Stocks
AptarGroup's Bidose approved by FDA for breakthrough treatment of depression »

Aptar Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 01

    May

  • 01

    May

XELA

Exela Technologies

$3.82

-0.03 (-0.78%)

16:57
03/18/19
03/18
16:57
03/18/19
16:57
Earnings
Exela Technologies sees FY19 revenue $1.66B-$1.7B, consensus $1.68B »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

XELA

Exela Technologies

$3.82

-0.03 (-0.78%)

16:56
03/18/19
03/18
16:56
03/18/19
16:56
Earnings
Exela Technologies reports Q4 revenue $399.6M, consensus $401.4M »

Reports Q4 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

BIO

Bio-Rad

$313.64

3.58 (1.15%)

16:55
03/18/19
03/18
16:55
03/18/19
16:55
Hot Stocks
Bio-Rad extends 10-K filing by 15 days to complete year-end procedures »

In a regulatory 8-K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AERI

Aerie Pharmaceuticals

$47.09

0.09 (0.19%)

16:55
03/18/19
03/18
16:55
03/18/19
16:55
Conference/Events
Aerie Pharmaceuticals management to meet with JMP Securities »

Group Dinner Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 19

    Mar

  • 08

    Apr

NOMD

Nomad Foods

$21.45

-0.07 (-0.33%)

16:54
03/18/19
03/18
16:54
03/18/19
16:54
Syndicate
Nomad Foods files to sell 20M ordinary shares »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.